Schiffman Gregory T. - 02 Mar 2022 Form 4 Insider Report for NANOMIX Corp

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 02 Mar 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Dec 2022, 20:06:36 UTC
Prior SEC filing: 23 Feb 2022
Next SEC filing: 03 Nov 2022
Source filing: View source filing
Reporting owner signature: /s/ Greg Schiffman

Key filing fact

Schiffman Gregory T. filed Form 4 for NANOMIX Corp on 21 Dec 2022.

Key facts

This page summarizes Schiffman Gregory T.'s Form 4 filing for NANOMIX Corp.
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 Dec 2022, 20:06.

Change

Previous filing in this sequence was filed on 23 Feb 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NNMX transaction

Common Stock

Conversion of derivative security

Transaction value
Shares: +36,167
Change %
Price
Shares after: 36,167
Date: 02 Mar 2022
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NNMX transaction Derivative

Non Qualified Stock Option (right to buy)

Award

Transaction value: $0
Shares: +12,920
Change %: +14%
Price: $0.000000
Shares after: 106,784
Date: 11 Oct 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 12,920
Exercise price: $0.6010
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

On March 2, 2022, the Reporting Person's Series C Preferred Stock automatically converted into an aggregate of 36,167 shares of the Issuer's common stock upon consummation of the Issuer's previously announced reverse stock split.

Footnote F2

The shares vest 100% on grant.